The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: An International Model
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 10 (2) , 98-116
- https://doi.org/10.1111/j.1524-4733.2006.00157.x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccineVaccine, 2003
- The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccinesVaccine, 2003
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003
- A Model to Estimate the Cost Benefit of an Occupational Vaccination Programme for Influenza with Influvac?? in the UK*PharmacoEconomics, 2002
- Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working AdultsJAMA, 2000
- The Impact of Influenza Epidemics on HospitalizationsThe Journal of Infectious Diseases, 2000
- The impact of influenza epidemics on mortality: introducing a severity index.American Journal of Public Health, 1997
- Sickness Absence Following a Campaign of Vaccination against Influenza in the WorkplaceOccupational Medicine, 1996
- The Effectiveness of Vaccination against Influenza in Healthy, Working AdultsNew England Journal of Medicine, 1995
- IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATIONAmerican Journal of Epidemiology, 1980